Recent advances in the drug treatment of inflammatory bowel disease (IBD) have paralleled
our understanding of the pathophysiology of ulcerative colitis and Crohn's disease. Several …

The cytokine responses characterizing the inflammatory bowel diseases are the key
pathophysiologic elements that govern the initiation, evolution, and, ultimately, the resolution …

The etiology of inflammatory bowel disease (IBD), of which ulcerative colitis (UC) and
Crohn's disease (CD) are the two most prevailing entities, is unknown. However, IBD is …

Introduction: Cytokines represent the key pathophysiologic elements that govern the
initiation, progression, and, in some circumstances, the resolution of the inflammation …

Crohn's disease (CD) and ulcerative colitis (UC), the two idiopathic inflammatory bowel
diseases (IBDs), affect almost two million individuals in North America and several million …

Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative
colitis (UC), represents a group of chronic disorders characterized by inflammation of the …

Conventional therapy for inflammatory bowel diseases rely on corticosteroids and 5-
aminosalicylates combined with immunosuppressive agents for maintenance. These drugs …

Crohn's disease is a chronic inflammatory bowel disease of unknown origin. The
understanding of the pathogenesis of inflammatory bowel diseases has been greatly …

Abstract Background and Aims Faecal diversion is associated with improvements in Crohn's
disease but not ulcerative colitis, indicating that differing mechanisms mediate the diseases …

Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory disorders of the
gastrointestinal tract that share clinical and pathological characteristics. The most accredited …